Salud financiera de hoja de balance de Illumina
Salud financiera controles de criterios 4/6
Illumina tiene un patrimonio de los accionistas total de $5.7B y una deuda total de $1.5B, lo que sitúa su ratio deuda-patrimonio en 25.9%. Sus activos y pasivos totales son $10.1B y $4.4B respectivamente.
Información clave
25.9%
Ratio deuda-patrimonio
US$1.49b
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$1.05b |
| Patrimonio | US$5.75b |
| Total pasivo | US$4.37b |
| Activos totales | US$10.11b |
Actualizaciones recientes sobre salud financiera
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Jan 26
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Oct 24Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt
Jun 13Is Illumina (NASDAQ:ILMN) Using Too Much Debt?
Mar 14These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well
Oct 27Recent updates
Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)
Apr 26Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)
Mar 20Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition
Feb 23Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Jan 26Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024
Jan 19Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%
Dec 21Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?
Dec 03Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Oct 24Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?
Oct 03At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?
Aug 22The Big Trends: New Frontiers in Healthcare
Jul 13
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Jul 03Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt
Jun 13Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Apr 12Is Illumina (NASDAQ:ILMN) Using Too Much Debt?
Mar 14Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?
Dec 30Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?
Dec 02These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well
Oct 27Illumina, GenoScreen collaborate on genomic testing for drug-resistant TB
Oct 18Illumina in research collaboration with AstraZeneca on drug target discovery
Oct 11Illumina Engages Obama To Push Its Customers' Reimbursement Agenda
Sep 29Illumina to appeal EU decision to block GRAIL acquisition
Sep 06Illumina Needs Grail, But May Lose It
Aug 30Illumina added to positive catalyst watch at Citi despite Q2 miss
Aug 22Illumina up 9% following drop after Q2 earnings
Aug 15Is It Too Late To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Aug 08Still Avoiding Illumina Stock
Aug 05Illumina, Grail deal unlikely to get EU nod – Reuters
Jul 27Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 48% Discount?
Jul 22Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($2.6B) de ILMN superan a sus pasivos a corto plazo ($1.6B).
Pasivo a largo plazo: Los activos a corto plazo ($2.6B) de ILMN no cubren sus pasivos a largo plazo ($2.8B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (7.6%) de ILMN se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de ILMN ha pasado de 44.2% a 25.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de ILMN está bien cubierta por el flujo de caja operativo (32.1%).
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de ILMN sobre su deuda están bien cubiertos por el EBIT.